SCHEMBL4948851

SCHEMBL4948851

COC(=O)CC1CCN(c2cccc(O)c2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
LMNA P02545 1/20 0.52
GAA P10253 1/20 0.52
MAPT P10636 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
FFAR4 Q5NUL3 4/20 0.47
DRD2 P14416 2/20 0.47
CHRM4 P08173 3/20 0.46
DEGS1 O15121 2/20 0.43
DRD3 P35462 1/20 0.43
ADRA1D P25100 1/20 0.43
ADRA1A P35348 1/20 0.43
ADRA1B P35368 1/20 0.43
VCP P55072 1/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
CHRM3 P20309 1/20 0.40
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
OPRM1 P35372 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25766536 0.78 VCP (0.48) FFAR4DRD2ADRA1DADRA1AADRA1B
SCHEMBL13114895 0.77 GFER (0.48) ALDH1A1LMNAGAAMAPTSMN1; SMN2
SCHEMBL20271749 0.77 DEGS1 (0.57) ALDH1A1LMNAMAPTSMN1; SMN2CHRM4
SCHEMBL20271986 0.77 DEGS1 (0.57) ALDH1A1LMNAMAPTSMN1; SMN2DRD2
SCHEMBL4952096 0.76 DRD2 (0.47) ALDH1A1LMNAGAAMAPTSMN1; SMN2
SCHEMBL5526338 0.76 NOTUM (0.59) DRD2CHRM4DRD3KMT2A
SCHEMBL32665119 0.76 CKS1B (0.53) DRD2CHRM4
SCHEMBL10148279 0.76 USP2 (0.60) ALDH1A1MAPTDEGS1KMT2A
SCHEMBL10148118 0.76 MAPT (0.56) ALDH1A1LMNAMAPTCHRM4MEN1
SCHEMBL2560547 0.75 FFAR4 (0.78) ALDH1A1MAPTSMN1; SMN2FFAR4DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7365085-B2 Compounds and methods SMITHKLINE BEECHAM CORPORATION (US) 2008-04-29 US disclosed
EP-1575495-A2 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2005-09-21 EP disclosed
US-20050113580-A1 Amide compounds and methods of using the same SMITHKLINE BEECHAM CORP 2005-05-26 US disclosed
WO-2003082205-A2 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2003-10-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113580-A1 Amide compounds and methods of using the same NR1H2, NR1H3, PPARA ALDH1A1 1460/4885LMNA 2469/4885GAA 1405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.